To further analyze the clinical significance of PD-1 and PD-L1 in our cases, we found that DLBCL patients with PD-1+ TILs had prolonged survival time, which contradicts with the suppressed role of PD-1 in immune response. Here, CD274 is linked to diffuse large B-cell lymphoma.